ACTINIUM PHARMACEUTICALS, INC. Interest Expense
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Interest Expense of $5.01 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2017-08-04
- ACTINIUM PHARMACEUTICALS, INC. interest expense for the quarter ending 2016-12-31 was $0.00.
- ACTINIUM PHARMACEUTICALS, INC. interest expense for the quarter ending 2016-09-30 was $666.00, a 13.27% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. interest expense for the quarter ending 2016-06-30 was $1.68K, a 8.37% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. interest expense for the quarter ending 2016-03-31 was $2.66K, a 53.59% decline year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. interest expense for fiscal 2016 was $5.01K, a 36.36% decline from fiscal 2015.
- ACTINIUM PHARMACEUTICALS, INC. interest expense for fiscal 2015 was $7.87K, a 808.55% increase from fiscal 2014.
- ACTINIUM PHARMACEUTICALS, INC. interest expense for fiscal 2014 was $866.00, a 65.47% decline from fiscal 2013.
- ACTINIUM PHARMACEUTICALS, INC. interest expense for fiscal 2013 was $2.51K, a 99.77% decline from fiscal 2012.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed | Interest Expense 151 month | Interest Expense 154 month | Interest Expense 157 month | Interest Expense 160 month | Interest Expense 163 month | Interest Expense 166 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $666.00 derived: sum of 2 quarters · filed 2017-03-16 | $2.35K derived: sum of 3 quarters · filed 2017-08-04 | $5.01K 10-K · filed 2017-03-16 | ||||||||||
| 2016-09-30 | $666.00 10-Q · filed 2016-10-28 | $2.35K derived: sum of 2 quarters · filed 2017-08-04 | $5.01K 10-Q · filed 2016-10-28 | $5.01K derived: sum of 4 quarters · filed 2017-08-04 | ||||||||||
| 2016-06-30 | $1.68K 10-Q · filed 2017-08-04 | $4.34K 10-Q · filed 2017-08-04 | $4.34K derived: sum of 3 quarters · filed 2017-08-04 | $4.93K derived: sum of 4 quarters · filed 2017-08-04 | ||||||||||
| 2016-03-31 | $2.66K 10-Q · filed 2017-05-15 | $2.66K derived: sum of 2 quarters · filed 2017-05-15 | $3.25K derived: sum of 3 quarters · filed 2017-05-15 | $4.80K derived: sum of 4 quarters · filed 2017-05-15 | ||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $588.00 derived: sum of 2 quarters · filed 2017-03-16 | $2.14K derived: sum of 3 quarters · filed 2017-03-16 | $7.87K 10-K · filed 2017-03-16 | ||||||||||
| 2015-09-30 | $588.00 10-Q · filed 2016-10-28 | $2.14K derived: sum of 2 quarters · filed 2016-10-28 | $7.87K 10-Q · filed 2016-10-28 | |||||||||||
| 2015-06-30 | $1.55K 10-Q · filed 2016-07-29 | $7.28K 10-Q · filed 2016-07-29 | ||||||||||||
| 2015-03-31 | $5.73K 10-Q · filed 2016-05-10 | |||||||||||||
| 2014-12-31 | $866.00 10-K · filed 2017-03-16 | |||||||||||||
| 2014-03-31 | $1.97M 10-Q · filed 2014-05-12 | |||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $1.30K derived: sum of 2 quarters · filed 2016-03-11 | $1.93K derived: sum of 3 quarters · filed 2016-03-11 | $2.51K 10-K · filed 2016-03-11 | $1.97M 10-K · filed 2014-02-28 | |||||||||
| 2013-09-30 | $1.30K 10-Q · filed 2014-10-31 | $1.93K derived: sum of 2 quarters · filed 2014-10-31 | $2.51K 10-Q · filed 2014-10-31 | $149.59K derived: sum of 4 quarters · filed 2014-10-31 | $1.97M 10-Q · filed 2013-11-14 | |||||||||
| 2013-06-30 | $634.00 10-Q · filed 2014-08-12 | $1.21K 10-Q · filed 2014-08-12 | $148.29K derived: sum of 3 quarters · filed 2014-08-12 | $466.92K derived: sum of 4 quarters · filed 2014-08-12 | $1.97M 10-Q · filed 2013-08-13 | |||||||||
| 2013-03-31 | $575.00 10-Q · filed 2014-05-12 | $147.66K derived: sum of 2 quarters · filed 2014-05-12 | $466.28K derived: sum of 3 quarters · filed 2014-05-12 | $787.01K derived: sum of 4 quarters · filed 2014-05-12 | $1.97M 10-Q · filed 2013-05-15 | |||||||||
| 2012-12-31 | $147.09K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $465.71K derived: sum of 2 quarters · filed 2014-02-28 | $786.44K derived: sum of 3 quarters · filed 2014-02-28 | $1.10M 10-K · filed 2014-02-28 | -$1.10M 10-K · filed 2013-03-29 | -$1.96M 10-K · filed 2013-03-29 | ||||||||
| 2012-09-30 | $318.62K 10-Q · filed 2013-11-14 | $639.35K derived: sum of 2 quarters · filed 2013-11-14 | $952.24K 10-Q · filed 2013-11-14 | -$4.04K 10-Q · filed 2012-11-14 | $950.92K derived: sum of 4 quarters · filed 2013-11-14 | |||||||||
| 2012-06-30 | $320.73K 10-Q · filed 2013-08-13 | $633.62K 10-Q · filed 2013-08-13 | $2.60K 10-Q/A · filed 2012-08-29 | $632.29K derived: sum of 3 quarters · filed 2013-08-13 | $626.19K derived: sum of 4 quarters · filed 2013-08-13 | |||||||||
| 2012-03-31 | $312.89K 10-Q · filed 2013-05-15 | -$1.21K 10-Q · filed 2012-04-23 | $311.56K derived: sum of 2 quarters · filed 2013-05-15 | $305.46K derived: sum of 3 quarters · filed 2013-05-15 | ||||||||||
| 2011-12-31 | -$1.32K 10-Q · filed 2012-04-23 | -$7.43K derived: sum of 2 quarters · filed 2012-11-14 | -$175.09K 10-K · filed 2013-03-29 | -$4.76K 10-K · filed 2012-04-12 | ||||||||||
| 2011-09-30 | -$6.10K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | -$3.59K 10-Q · filed 2012-11-14 | $3.59K 10-Q · filed 2011-11-14 | |||||||||||
| 2011-06-30 | $2.51K 10-Q/A · filed 2012-08-29 | |||||||||||||
| 2010-12-31 | -$11.59K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-12 | -$10.04K derived: sum of 2 quarters · filed 2012-04-12 | -$6.44K 10-K · filed 2012-04-12 | |||||||||||
| 2010-09-30 | $1.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $5.15K 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | $3.60K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |